LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,442,906 | +13.0% | 36,369 | +16.1% | 0.01% | 0.0% |
| Q2 2023 | $2,162,641 | +36.6% | 31,329 | -4.6% | 0.01% | +25.0% |
| Q1 2023 | $1,582,822 | +28.0% | 32,825 | +29.3% | 0.00% | +33.3% |
| Q4 2022 | $1,236,298 | +14.9% | 25,386 | -3.8% | 0.00% | 0.0% |
| Q3 2022 | $1,076,000 | -25.5% | 26,377 | +0.5% | 0.00% | -50.0% |
| Q2 2022 | $1,444,000 | +53.6% | 26,256 | +1.5% | 0.01% | +50.0% |
| Q1 2022 | $940,000 | +34.1% | 25,869 | +77.9% | 0.00% | +33.3% |
| Q4 2021 | $701,000 | +63.0% | 14,543 | +71.2% | 0.00% | +50.0% |
| Q3 2021 | $430,000 | +23.2% | 8,495 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $349,000 | – | 8,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |